Literature DB >> 9608317

Update on immunosuppressive therapy.

N G Singer1, W J McCune.   

Abstract

In this review we summarize selected articles that have been published about immunosuppressive agents in the past year. These studies fall into three major categories: 1) use of pulse cyclophosphamide in autoimmune diseases other than systemic lupus erythematosus; 2) use of newer immunosuppressive agents such as cyclosporine and FK506 in a variety of rheumatic diseases; and 3) toxicity.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9608317     DOI： 10.1097/00002281-199805000-00003

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN： 1040-8711            Impact factor:   5.006


  6 in total

Review 1.  Pulmonary manifestations of Behçet's disease.

Authors:  F Erkan; A Gül; E Tasali
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

Review 2.  Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosus.

Authors:  Juergen Foell; Robert S Mittler
Journal:  Springer Semin Immunopathol       Date:  2006-09-02

Review 3.  Autophagy as a target for glucocorticoid-induced osteoporosis therapy.

Authors:  Gengyang Shen; Hui Ren; Qi Shang; Ting Qiu; Xiang Yu; Zhida Zhang; Jinjing Huang; Wenhua Zhao; Yuzhuo Zhang; Xiaobing Jiang
Journal:  Cell Mol Life Sci       Date:  2018-02-09       Impact factor: 9.261

Review 4.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.

Authors:  Kiyoshi Migita; Yukihiro Akeda; Manabu Akazawa; Shigeto Tohma; Fuminori Hirano; Haruko Ideguchi; Ryutaro Matsumura; Eiichi Suematsu; Tomoya Miyamura; Shunsuke Mori; Takahiro Fukui; Yasumori Izumi; Nozomi Iwanaga; Hiroshi Tsutani; Kouichirou Saisyo; Takao Yamanaka; Shiro Ohshima; Takao Sugiyama; Yojiro Kawabe; Masao Katayama; Yasuo Suenaga; Akira Okamoto; Hisaji Ohshima; Yasumasa Okada; Kenji Ichikawa; Shigeru Yoshizawa; Kenji Kawakami; Toshihiro Matsui; Hiroshi Furukawa; Kazunori Oishi
Journal:  Arthritis Res Ther       Date:  2015-06-03       Impact factor: 5.156

6.  Innate immune response after acute myocardial infarction and pharmacomodulatory action of tacrolimus in reducing infarct size and preserving myocardial integrity.

Authors:  Jiunn-Jye Sheu; Pei-Hsun Sung; Steve Leu; Han-Tan Chai; Yen-Yi Zhen; Yi-Ching Chen; Sarah Chua; Yung-Lung Chen; Tzu-Hsien Tsai; Fan-Yen Lee; Hsueh-Wen Chang; Sheung-Fat Ko; Hon-Kan Yip
Journal:  J Biomed Sci       Date:  2013-10-29       Impact factor: 8.410
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.